Temporal interference stimulation rescues dopaminergic neurons in the substantia nigra of MPTP-induced Parkinson's disease mice via inhibition of lipid peroxidation. [PDF]
Sun L +7 more
europepmc +1 more source
Acute and Chronic Local Field Potential Recordings in Dystonia—A Systematic Review
Abstract Dystonia is a hyperkinetic movement disorder increasingly conceptualized as a disorder of distributed network dysfunction involving the basal ganglia, cortex and cerebellum. Local field potentials (LFPs) recorded from deep brain stimulation (DBS) electrodes provide a unique opportunity to characterize the electrophysiological signatures ...
Jack Horan +6 more
wiley +1 more source
The human LRRK2-R1441G mutation drives age-dependent oxidative stress and mitochondrial dysfunction in dopaminergic neurons. [PDF]
Chen Y +5 more
europepmc +1 more source
Abstract Background Parkinson's disease (PD) progression is highly heterogeneous, complicating clinical management and prognostication. While machine learning models have been developed using research datasets such as Parkinson's Precision Medicine Initiative (PPMI) and Parkinson's Disease Biomarkers Program (PDBP), their clinical translatability is ...
Xuehua Ye +9 more
wiley +1 more source
Neuromodulatory control of energy reserves in dopaminergic neurons. [PDF]
Pulido C, Gentry MS, Ryan TA.
europepmc +1 more source
Modeling Parkinson's pathology in human iPSC dopaminergic neurons uncovers key mechanisms of Lewy body formation and heterogeneity. [PDF]
Mahul-Mellier AL +16 more
europepmc +1 more source
The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease
Abstract Background Parkinson's disease (PD) and sensorineural hearing loss (SNHL) are both prevalent conditions among older adults. Although increasing number of studies have investigated SNHL as a risk factor for PD, it is not well known how diagnosed PD affects the likelihood of SNHL diagnosis.
Kaisa Hokkinen +4 more
wiley +1 more source
Simvastatin Protects the Dopaminergic Neurons from MPTP-Mediated Injury by Inducing BDNF via PPARα Activation. [PDF]
Bohara G +4 more
europepmc +1 more source
Exercise and Motor Complications in Parkinson's Disease: A Systematic Review and Meta‐Analysis
Abstract Background Levodopa remains the most effective pharmacological treatment for Parkinson's disease (PD), but long‐term use commonly leads to motor complications such as levodopa‐induced dyskinesia (LID) and motor fluctuations, significantly contributing to disability. Exercise is well‐established for improving motor and non‐motor symptoms in PD;
Priscila Nóbrega‐Sousa +5 more
wiley +1 more source
Engineering functional ventral midbrain dopaminergic neurons in human organoids through WNT modulation and bioreactor culture. [PDF]
Raji H +5 more
europepmc +1 more source

